Invention Grant
US08865167B2 Neutralising antibody molecules having specificity for human IL-17
有权
具有对人IL-17具有特异性的中和抗体分子
- Patent Title: Neutralising antibody molecules having specificity for human IL-17
- Patent Title (中): 具有对人IL-17具有特异性的中和抗体分子
-
Application No.: US13709055Application Date: 2012-12-09
-
Publication No.: US08865167B2Publication Date: 2014-10-21
- Inventor: Ralph Adams , Andrew George Popplewell , Stephen Edward Rapecki , Simon Peter Tickle
- Applicant: UCB Pharma S.A.
- Applicant Address: BE Brussels
- Assignee: UCB Pharma, S.A.
- Current Assignee: UCB Pharma, S.A.
- Current Assignee Address: BE Brussels
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: GB0425569.1 20041119
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/00 ; A61K47/48 ; C07K16/24 ; C07K16/46
Abstract:
The invention relates to an antibody molecule having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecule and methods for producing said antibody molecule.
Public/Granted literature
- US20130245229A1 Neutralising Antibody Molecules Having Specificity for Human IL-17 Public/Granted day:2013-09-19
Information query
